All Stories

  1. Structural, supramolecular analysis, and photoluminescence properties of a new hydroxybenzohydrazide Schiff base
  2. Copper(II)-5-chloro-2-hydroxybenzophenone Complexes with N – N Donors: Structural Insights and Antitumor Activity against A2780 Human Ovarian Cancer Cells of ...
  3. An integrated NMR and DFT study on the conformational preferences of N-alkyl benzamides
  4. Manganese‐Induced Production of Antioxidant Polyene Steroids in the Extremophile Fungus Talaromyces fuscoviridis Isolated From Copper‐Mine Soil
  5. New Naphthoquinone‐Based Manganese (II) Complexes: Synthesis, Characterization, and Cytotoxicity
  6. Use of computational techniques in Raman spectra analysis
  7. Ascorbyl Radicals as Reducing Agents in Copper-Catalyzed Redox Reactions
  8. The Vortex-Slurry Implementation: A Cheap, Easy, and Ultrafast Mechanochemical Tool to Synthesize/Screen Pharmaceutical Salts and Cocrystals
  9. A supersaturated glass-melt approach for growing micrometer-sized TGG single crystals
  10. Enhanced Anticancer Potential of Pd(II)-Thiosemicarbazone Complexes: Selectivity, Mechanisms, and 3D Models
  11. Innovative synthesis of Tm³⁺/Er³⁺-doped Yb-YGG single crystals for upconversion-based white light emission
  12. Ru(II)-Fenamic-Based Complexes as Promising Human Ovarian Antitumor Agents: DNA Interaction, Cellular Uptake, and Three-Dimensional Spheroid Models
  13. A new anthelmintic salt
  14. Enhancing physicochemical properties of hydrochlorothiazide with zwitterionic L-proline and 5-fluorocytosine cocrystals through mechanochemical synthesis
  15. Ruthenium(II) Complex with 1-Hydroxy-9,10-Anthraquinone Inhibits Cell Cycle Progression at G0/G1 and Induces Apoptosis in Melanoma Cells
  16. A novel imatinib analogue inhibitor of chronic myeloid leukaemia: design, synthesis and characterization—explanation of its folded conformation
  17. A nickel glutamate metal biomolecule framework
  18. Dual spectral and temporal encoding in luminescent polymeric films using a EuIII complex and a persistent phosphor for anti-counterfeiting applications
  19. Reactions of ketosulfoxonium ylides with allylic carbocations: stereoselective and direct access to highly-substituted cyclo-propanes and α-alkylated ylides
  20. Diastereoselective Synthesis of Highly Functionalized γ‐Lactams via Ugi Reaction/Michael Addition
  21. A new ciprofibrate calcium salt with improved solubility and intrinsic dissolution rate
  22. NMR and X-ray diffraction conformational study of guanidines
  23. Synthesis, XRD structural analysis and theoretical studies of a potential inhibitor against rheumatoid arthritis (RA)
  24. Reactivity of the p‐Cymene‐Ruthenium Complex with Two Phenylamines for Metathesis Polymerization of Norbornene Compared to the Reactivity of Complexes with a Single Benzylamine or Dibenzylamine
  25. Structural Properties and Charge Redistribution in Cocrystallized Pharmaceutical Ingredients: A Comparative Experimental and Theoretical Charge Density Analysis
  26. Synthesis, characterization and structural analysis of complexes from 2,2′:6′,2′′-terpyridine derivatives with transition metals
  27. Controlled synthesis and structure characterization of a new fluconazole polymorph using analytical techniques and multivariate method
  28. Study of the Conformation of Bromated Guanidines with Potential Anti-leishmania Activity
  29. Use of Mechanochemical Methodology to Explore the Formation of a New Crystalline Phase in the Curcumin‐Quercetin System
  30. Intensity and lifetime ratiometric luminescent thermometer based on a Tb(iii) coordination polymer
  31. Versatile Applications of Cyanoacetic Acid in Organic Chemistry: Active Methylene Compound for the Knoevenagel Condensation and Organocatalyst for the Biginelli Reaction
  32. Structural and Anticancer Studies of Methoxyflavone Derivative from Strychnos pseudoquina A.St.-Hil. (Loganiaceae) from Brazilian Cerrado
  33. Synthesis, Characterization, DNA Binding and Cytotoxicity of Copper(II) Phenylcarboxylate Complexes
  34. Synthesis, Characterization and Structural Analysis of Two New Biguanide Complexes
  35. Crystalline and amorphous famotidine malate as pathways to prevent polymorphic transformation with improved dissolution
  36. Nitrosyl/Diphenylphosphine/Amino Acid–Ruthenium Complexes as Inhibitors of MDA-MB-231 Breast Cancer Cells
  37. Molecular structure of Ru(II)/diphosphine/4,6-dimethyl-2-pyrimidinethiol complexes: A combined experimental and density functional theory study
  38. Drug Repurposing of the Antiviral Drug Acyclovir: New Pharmaceutical Salts
  39. Development of Copper Complexes with Diimines and Dipicolinate as Anticancer Cytotoxic Agents
  40. “Half-Sandwich” Ruthenium Complexes with Alizarin as Anticancer Agents: In Vitro and In Vivo Studies
  41. Tuning the Thermometric Features in 1D Luminescent EuIII and TbIII Coordination Polymers through Different Bridge Phosphine Oxide Ligands
  42. It Takes Two to Tango, Part II: Synthesis of A-Ring Functionalised Quinones Containing Two Redox-Active Centres with Antitumour Activities
  43. New Copper(II)-L-Dipeptide-Bathophenanthroline Complexes as Potential Anticancer Agents—Synthesis, Characterization and Cytotoxicity Studies—And Comparative DNA-Binding Study of Related Phen Complexes
  44. Spontaneous Resolution of RS-Fluoxetine to a Racemic Conglomerate upon Salt Formation with Oxalic Acid
  45. Activation–Deactivation of Inter-Peptide Bond in Fluoro-N-(2-hydroxy-5-methyl phenyl)benzamide Isomers, Induced by the Position of the Halogen Atom in the Benzene Ring
  46. Highlighting Recent Crystalline Engineering Aspects of Luminescent Coordination Polymers Based on F-Elements and Ditopic Aliphatic Ligands
  47. Synthesis and Evaluation of Antibacterial Activity of 1,2,3-Triazole and Ether Derivatives of Paeonol
  48. Roméite-Group Minerals Review: New Crystal Chemical and Raman Data of Fluorcalcioroméite and Hydroxycalcioroméite
  49. Vibrational and conformational analysis of structural phase transition in Estradiol 17β valerate with temperature
  50. Estudio estructural y supramolecular del ácido 2-E-((4-hidroxifenil) diazenil) benzoico
  51. Crystal Engineering in the design of New Solid Pharmaceutical Forms with enhanced pharmaceutical properties
  52. Amino–Imino Tautomerism in the Salt Formation of Albendazole: Hydrobromide and Nitrate Salts
  53. Glycosylated narciclasine alkaloid in Hippeastrum puniceum (Lam.) Kuntze
  54. Synthesis and X-ray crystal structures of polyfunctionalized 4H-chromene derivatives via tricomponent reaction with Knoevenagel adducts as intermediates in aqueous medium
  55. Molecular Structure Studies on Allyl Sulfonamides: Synthesis, Theoretical Treatment and Evaluation of Biological Activity
  56. meso-Tetra-(4-pyridyl)porphyrin/palladium(ii) complexes as anticancer agents
  57. Study of secondary porosity by SAXS and N 2 adsorption in composite materials obtained from a Cuban natural clinoptilolite
  58. Silver complexes with fluoroanthranilic acid isomers: Spectroscopic characterization, antimycobacterial activity and cytotoxic studies over a panel of tumor cells
  59. Synthesis and structural characterization of a series of ternary copper(II)-L-dipeptide-neocuproine complexes. Study of their cytotoxicity against cancer cells including MDA-MB-231, triple negative breast cancer cells
  60. Zeolite/ZnO composites based on a Cuban natural clinoptilolite and preliminary evaluation in methylene blue adsorption
  61. Biguanide–transition metals complexes as potential drug for hyperglycemia treatment
  62. Chain-like uranyl-coordination polymer as a bright green light emitter for sensing and sunlight driven photocatalysis
  63. Chemical transformation of a luminescent two-dimensional Eu(iii) coordination polymer in the aqueous phase
  64. Crystal structure, anti-Trypanosoma cruzi and cytotoxic activities of Cu(II) complexes bearing β-diketone and α-diimine ligands
  65. New Allyldithiocarbimates: Synthesis, Structure and Antifungal Activity against Phakopsora pachyrhizi and Hemileia vastatrix
  66. Synthesis and solid-state characterization of diclofenac imidazolium monohydrate: an imidazolium pharmaceutical ionic liquid
  67. “Half-Sandwich”/RuII Anticancer Complexes Containing Triphenylphosphine and p-Substituted Benzoic Acids
  68. Silver(i) complexes of 3-methoxy-4-hydroxybenzaldehyde thiosemicarbazones and triphenylphosphine: structural, cytotoxicity, and apoptotic studies
  69. Rational design, supramolecular synthesis and solid state characterization of two bicomponent solid forms of mebendazole
  70. Green One-Pot Asymmetric Synthesis of Peptidomimetics via Sequential Organocatalyzed Aziridination and Passerini Multicomponent Reaction
  71. Data of synthesis, characterization and luminescence measurements in 1D lanthanide coordination polymers based on lanthanides
  72. Synthesis, spectroscopic (FT–IR and UV–Vis), crystallographic and theoretical studies, and a molecular docking simulation of an imatinib-like template
  73. Green Synthetic Methodology of (E)-2-cyano-3-aryl Selective Knoevenagel Adducts Under Microwave Irradiation
  74. Ru(II) complexes containing uracil nucleobase analogs with cytotoxicity against tumor cells
  75. THERMAL BEHAVIOR OF INOSINE 5’-MONOPHOSPHATE COMPLEXES WITH COBALT(II), NICKEL(II), COPPER(II) AND CADMIUM(II) CATIONS
  76. Crystal structures of two CuII compounds: catena-poly[[chloridocopper(II)]-μ-N-[ethoxy(pyridin-2-yl)methylidene]-N′-[oxido(pyridin-3-yl)methylidene]hydrazine-κ4 N,N′,O:
  77. 1D lanthanide coordination polymers based on lanthanides and 4′-hydroxi-4-biphenylcarboxylic acid: Synthesis, structures and luminescence properties
  78. Synthesis, structural characterization, and theoretical studies of new pyrazole (E)-2-{[(5-(tert-butyl)-1H-pyrazol-3-yl)imino]methyl}phenol and (E)-2-{[(1-(4-bromophenyl)-3-(tert-butyl)-1H-pyrazol-5-yl]imino]methyl}phenol
  79. Isolation, Identification, Predictions of Biological Activity and Molecular Docking of the Diterpene Jateorin Obtained from the Stem of Odontocarya tamoides (D.C.) Miers
  80. A simple alternative to prodrug: The hydrochloride salt monohydrate of the prostate anticancer drug abiraterone
  81. Ru(II)/N-N/PPh3 complexes as potential anticancer agents against MDA-MB-231 cancer cells (N-N = diimine or diamine)
  82. Nickel complexes with phosphines and N-R-sulfonyldithiocarbimates ligands: New antifungals for the control of Hemileia vastatrix and Phakopsora pachyrhizi
  83. Fluconazole: Synthesis and Structural Characterization of Four New Pharmaceutical Cocrystal Forms
  84. Esterification of the free carboxylic group from the lutidinic acid ligand as a tool to improve the cytotoxicity of Ru(ii) complexes
  85. X-ray diffraction, vibrational and thermal study of dibenzazepinodione, a pharmacopeial impurity of oxcarbazepine
  86. Fluconazolium oxalate: synthesis and structural characterization of a highly soluble crystalline form
  87. When Serendipity Knocks on the Door: Synthesis and Physicochemical Characterization of 7-Chloro-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidin-5-one
  88. Pharmaceutical paroxetine-based organic salts of carboxylic acids with optimized properties: the identification and characterization of potential novel API solid forms
  89. Supramolecular synthesis and characterization of crystalline solids obtained from the reaction of 5-fluorocytosine with nitro compounds
  90. Highly water soluble agrichemicals by using engineered organic salts for reducing adverse environmental impacts
  91. APLICAÇÃO DA ESPECTROSCOPIA RAMAN NA CARACTERIZAÇÃO DE MINERAIS PERTENCENTES A UMA GEOCOLEÇÃO
  92. In vitro Antiplasmodial Activities of Alkaloids Isolated from Roots of Worsleya procera (Lem.) Traub (Amaryllidaceae)
  93. In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex
  94. In vitro cytotoxicity and in vivo zebrafish toxicity evaluation of Ru(ii)/2-mercaptopyrimidine complexes
  95. Spergulagenic Acid A: Isolation and single crystal structure elucidation
  96. Modulating the water solubility and thermal stability of the anti-tuberculosis drug Isoniazid via multicomponent crystal formation
  97. Development of copper(II)-diimine-iminodiacetate mixed ligand complexes as potential antitumor agents
  98. The use of variable temperature 13 C solid-state MAS NMR and GIPAW DFT calculations to explore the dynamics of diethylcarbamazine citrate
  99. In vitro leishmanicidal activity and theoretical insights into biological action of ruthenium(II) organometallic complexes containing anti-inflammatories
  100. Rational Design of a Famotidine–Ibuprofen Coamorphous System: An Experimental and Theoretical Study
  101. Crystal Structure of N-(2-Cyano-1-Phenylprop-2-en-1-yl)-4-Methylbenzenesulfonamide
  102. Mechanochemical Synthesis of a Multicomponent Solid Form: The Case of 5-Fluorocytosine Isoniazid Codrug
  103. Synthesis, crystal structure, photophysical properties and theoretical studies of a novel bis(phenylisoxazolyl) benzene derivative
  104. Co-crystal structure of a dinuclear (Zn-Y) and a trinuclear (Zn-Y-Zn) complexes derived from a Schiff base ligand
  105. 5-Fluorocytosine/5-Fluorouracil Drug-Drug Cocrystal: a New Development Route Based on Mechanochemical Synthesis
  106. Protonation of inorganic 5-Fluorocytosine salts
  107. Synthesis, characterization and solubility of a new anthelmintic salt: Mebendazole nitrate
  108. Novel Solid Solution of the Antiretroviral Drugs Lamivudine and Emtricitabine
  109. Cytotoxic activity and structural features of Ru(II)/phosphine/amino acid complexes
  110. Paroxetine and Fluoxetine Hexafluorosilicate salts: Synthesis, crystal structure, Hirshfeld surface, and supramolecular analysis
  111. {1-[1-(2-Hydroxyphenyl)ethylidene]-2-(pyridin-2-yl-κN)hydrazine-κ2 N′,O}{1-[1-(2-oxidophenyl)ethylidene]-2-(pyridin-2-yl-κN)hydrazine-κ2 N′,O}nickelate(...
  112. Antimicrobial activity of cis -[Ru(bpy) 2 (L)(L′)] n + complexes, where L = 4-(4-chlorobenzoyl)pyridine or 4-(benzoyl)pyridine and L′ = Cl − or CO
  113. Crystalline structure of the marketed form of Rifampicin: a case of conformational and charge transfer polymorphism
  114. Novel Isoniazid cocrystals with aromatic carboxylic acids: Crystal engineering, spectroscopy and thermochemical investigations
  115. Ru(ii)–thyminate complexes: new metallodrug candidates against tumor cells
  116. A vanillin-based copper(ii) metal complex with a DNA-mediated apoptotic activity
  117. Avoiding irreversible 5-fluorocytosine hydration via supramolecular synthesis of pharmaceutical cocrystals
  118. Facile Synthesis and Characterization of Symmetric N-[(Phenylcarbonyl) carbamothioyl]benzamide Thiourea: Experimental and Theoretical Investigations
  119. Exploring physical and chemical properties in new multifunctional indium-, bismuth-, and zinc-based 1D and 2D coordination polymers
  120. Crystal engineering of multicomponent crystal forms of antituberculosis drugs
  121. Crystallochemical characterization of polyoxometalate new minerals
  122. Synthesis, characterization and reactivity of halides/pseudohalides and their complexes containing ruthenium II in the hydrogenation of cyclohexene
  123. Conformational and structural diversity of iridium dimethyl sulfoxide complexes
  124. Probing intermolecular interactions in a diethylcarbamazine citrate salt by fast MAS 1 H solid-state NMR spectroscopy and GIPAW calculations
  125. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells
  126. Spectroscopic (far or terahertz, mid-infrared and Raman) investigation, thermal analysis and biological activity of piplartine
  127. Synthesis, structural characterization and cytotoxic activity against tumor cells of heteroleptic copper (I) complexes with aromatic diimines and phosphines
  128. Ru(II)/diphenylphosphine/pyridine-6-thiolate complexes induce S-180 cell apoptosis through intrinsic mitochondrial pathway involving inhibition of Bcl-2 and p53/Bax activation
  129. Photochemical studies of cis -[Ru(bpy) 2 (4-bzpy)(CO)](PF 6 ) 2 and cis -[Ru(bpy) 2 (4-bzpy)(Cl)](PF 6 ): Blue light-induced nucleobase binding
  130. Ruthenium(II)/triphenylphosphine complexes: An effective way to improve the cytotoxicity of lapachol
  131. Development of a salt drug with improved solubility: Ethionamide nitrate
  132. Propyl gallate metal complexes: Circular dichroism, BSA-binding, antioxidant and cytotoxic activity
  133. Hydroxycalciomicrolite, Ca1.5Ta2O6(OH), a new member of the microlite group from Volta Grande pegmatite, Nazareno, Minas Gerais, Brazil
  134. Reducing the Hygroscopicity of the Anti-Tuberculosis Drug (S,S)-Ethambutol Using Multicomponent Crystal Forms
  135. Reactive nitrogen/oxygen species production by nitro/nitrosyl supramolecular ruthenium porphyrin complexes
  136. Copper(I)–Phosphine Polypyridyl Complexes: Synthesis, Characterization, DNA/HSA Binding Study, and Antiproliferative Activity
  137. Syntheses, characterization and antifungal activity of novel dimethylbis(N-R-sulfonyldithiocarbimato)stannate(IV) complexes
  138. Order–disorder phase transition induced by proton transfer in a co-crystal of 2,4-dichlorobenzoic acid and trimethylamine N-oxide
  139. A Potential Visible-Light NO Releaser: Synthesis, Reactivity and Vasodilator Properties
  140. Polypyridyl Ruthenium Complexes: Novel DNA-Intercalating Agents against Human Breast Tumor
  141. Structural isomerism of Ru(ii)-carbonyl complexes: synthesis, characterization and their antitrypanosomal activities
  142. Studies on the Ru(II) monocationic complexes [RuCl 2 (NO)(P–N)(PR 3 )]PF 6 , where P–N = o -diphenylphosphino- N , N -dimethylaniline, and R = Ph and p -X-C 6 H 4 (X = OMe, Me, F)
  143. Ru(II)/bisphosphine/diimine/amino acid complexes: diastereoisomerism, cytotoxicity, and inhibition of tumor cell adhesion to collagen type I
  144. Correction to Rare Case of Polymorphism in a Racemic Fluoxetine Nitrate Salt: Phase Behavior and Relative Stability
  145. Solution and Solid State Nuclear Magnetic Resonance Spectroscopic Characterization of Efavirenz
  146. X-Ray diffraction, spectroscopy and thermochemical characterization of the pharmaceutical paroxetine nitrate salt
  147. Diffractaic acid: Crystalline structure and physicochemical characterization
  148. On the Thermal Stability of the Diethylcarbamazine-Fortified Table Salt Used in the Control of Lymphatic Filariasis
  149. Rare Case of Polymorphism in a Racemic Fluoxetine Nitrate Salt: Phase Behavior and Relative Stability
  150. Centrosymmetric resonance-assisted intermolecular hydrogen bonding chains in the enol form of β-diketone: Crystal structure and theoretical study
  151. Syntheses, characterization and antifungal activity of heteroleptic nickel(II) complexes with N-alkylsulfonyldithiocarbimates and phosphines
  152. Cationic Pd(II) complexes acting as topoisomerase II inhibitors: Synthesis, characterization, DNA interaction and cytotoxicity
  153. Reversible Solid-State Hydration/Dehydration of Paroxetine HBr Hemihydrate: Structural and Thermochemical Studies
  154. Looking for the interactions between omeprazole and amoxicillin in a disordered phase. An experimental and theoretical study
  155. Tetraphenylphosphonium allyldithiocarbimates derived from Morita-Baylis-Hillman adducts: Synthesis, characterization, crystal structure and antifungal activity
  156. Tuning the structure, dimensionality and luminescent properties of lanthanide metal–organic frameworks under ancillary ligand influence
  157. Supramolecular synthesis and thermochemical investigations of pharmaceutical inorganic isoniazid salts
  158. Rare earth coordination dinuclear compounds constructed from 3,5-dicarboxypyrazolate and succinate intermetallic bridges
  159. Influence of gold nanoparticles applied to catalytic hydrogenation of acetophenone with cationic complexes containing ruthenium
  160. Mechanochemistry applied to reformulation and scale-up production of Ethionamide: Salt selection and solubility enhancement
  161. Luminescence, chemical sensing and mechanical properties of crystalline materials based on lanthanide–sulfonate coordination polymers
  162. Chiral Platinum(II) Complexes Featuring Phosphine and Chloroquine Ligands as Cytotoxic and Monofunctional DNA-Binding Agents
  163. Crystal structure of 4-formyl-2-nitrophenyl 4-chloro-2-nitrobenzoate
  164. Crystal structure of 2-(4-chlorobenzamido)benzoic acid
  165. Cis-[RuCl(BzCN)(N–N)(P–P)]PF6 complexes: Synthesis and in vitro antitumor activity
  166. Vibrational and thermal analyses of multicomponent crystal forms of the anti-HIV drugs lamivudine and zalcitabine
  167. Exploring the System Lanthanide/Succinate in the Formation of Porous Metal–Organic Frameworks: Experimental and Theoretical Study
  168. Crystal structure and catalytic activity of ruthenium (II)/dithiocarbamate complexes in the epoxidation of cyclooctene
  169. Copper(II) complexes with β-diketones and N-donor heterocyclic ligands: Crystal structure, spectral properties, and cytotoxic activity
  170. Isostructurality and the conformational role of the 2′,3′-moieties in the diversity of lamivudine crystal forms probed in halide salts
  171. Anti-Mycobacterium tuberculosisand Cytotoxicity Activities of Ruthenium(II)/Bipyridine/Diphosphine/Pyrimidine-2-thiolate Complexes: The Role of the Non-CoordinatedN-Atom
  172. Ruthenium(II) complexes with hydroxypyridinecarboxylates: Screening potential metallodrugs against Mycobacterium tuberculosis
  173. Crystal Growth & Design Celebrates the International Year of Crystallography 2014
  174. DFT investigation on hydrogen bonding in cyclohexane-1,2,3,4,5-pentol crystal structure
  175. Crystal structure of 4-bromo-N-(2-hydroxyphenyl)benzamide
  176. Crystal structure of 2-nitro-N-(5-nitro-1,3-thiazol-2-yl)benzamide
  177. Crystal structure of (±)-3-[(benzo[d][1,3]dioxol-5-yl)methyl]-2-(3,4,5-trimethoxyphenyl)-1,3-thiazolidin-4-one
  178. Temperature-Driven Isosymmetric Reversible Phase Transition of the Hormone Estradiol 17β Valerate
  179. Solid-State Supramolecular Synthesis Based on the N–H…O Heterosynthon: An Approach to Solve the Polymorphism Problem in Famotidine
  180. Saddle-shaped macrocycle distortion and symmetry decrease in cobalt (II) meso-tetraphenylporphyrin: Structure of a dichloromethane solvate and DFT calculations
  181. Effect of the Methanol Molecule on the Stabilization of C 18 H 18 O 4 Crystal: Combined Theoretical and Structural Investigation
  182. Structural features and cytotoxic activities of [Ru(AA-H)(dppb)(bipy)]PF6 complexes
  183. Synthesis, structural characterization and cytotoxic activity of ternary copper(II)–dipeptide–phenanthroline complexes. A step towards the development of new copper compounds for the treatment of cancer
  184. Controlled Synthesis of New 5-Fluorocytosine Cocrystals Based on the p K a Rule
  185. Nitro/Nitrosyl-Ruthenium Complexes Are Potent and Selective Anti-Trypanosoma cruzi Agents Causing Autophagy and Necrotic Parasite Death
  186. Modified glassy carbon electrode with AuNPs using cis-[RuCl(dppb)(bipy)(4-vpy)]+ as crossed linking agent
  187. Antiparasitic activities of novel ruthenium/lapachol complexes
  188. fac-[1,2-Bis(pyridin-4-yl)ethane-κN]tricarbonyl(1,10-phenanthroline-κ2N,N′)rhenium(I) hexafluoridophosphate acetonitrile monosolvate
  189. [4-(Allyloxy)phenyl](phenyl)methanone
  190. 2,4,6-Trinitrophenyl 3-bromobenzoate
  191. 2-[(1-Oxidopyridin-4-yl)sulfanyl]benzoic acid
  192. 3-(Diphenylamino)isobenzofuran-1(3H)-one
  193. Synthesis, characterization and phytotoxic activity of hydroxylated isobenzofuran-1(3H)-ones
  194. Halogen⋯halogen contacts for the stabilization of a new polymorph of 9,10-dichloroanthracene
  195. 2,2′-(1,4-Phenylene)bis(propane-2,2-diyl) bis(benzodithioate)
  196. Quasi-enantiomeric single-nucleoside and quasi-racemic two-nucleoside hydrochloride salts and ruthenium complexes of cytidine and 2′,3′-dideoxycytidine analogs unveiling the negligible structure-driving role of the 2′,3′-moieties
  197. Unusual hydrogen bond patterns contributing to supramolecular assembly: conformational study, Hirshfeld surface analysis and density functional calculations of a new steroid derivative
  198. Novel polymorphs of the anti-Trypanosoma cruzi drug benznidazole
  199. Ruthenium(II)/4,6-dimethyl-2-mercaptopyrimidine complexes: Synthesis, characterization, X-ray structures and in vitro cytotoxicity activities on cancer cell lines
  200. Structural and vibrational study of 8-hydroxyquinoline-2-carboxaldehyde isonicotinoyl hydrazone – A potential metal–protein attenuating compound (MPAC) for the treatment of Alzheimer’s disease
  201. 4-Formyl-2-nitrophenyl 2-chlorobenzoate
  202. The Continuum in 5-Fluorocytosine. Toward Salt Formation
  203. Mebendazole Mesylate Monohydrate: A New Route to Improve the Solubility of Mebendazole Polymorphs
  204. Fluorcalciomicrolite, (Ca, Na, 〈)2Ta2O6F, a new microlite-group mineral from Volta Grande pegmatite, Nazareno, Minas Gerais, Brazil
  205. The effect of guest molecules on the conformation and molecular assembly of the fac-[RuCl3(NO)(dppb)] complex
  206. NH⋯Br, Br⋯π and π⋯π interactions toward self-assembly of the cytosine hydrobromide: Crystal structure, infrared spectroscopy and thermal behavior
  207. 2-[1′-(Benzyloxy)spiro[indane-1,2′-pyrrolidine]-5′-yl]acetonitrile
  208. (±)-3-(5-Amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-benzofuran-1(3H)-one
  209. Industrial Scale Isolation, Structural and Spectroscopic Characterization of Epiisopiloturine from Pilocarpus microphyllus Stapf Leaves: A Promising Alkaloid against Schistosomiasis
  210. 2,4,6-Trinitrophenyl 3-chlorobenzoate
  211. Supramolecular study, Hirshfeld analysis and theoretical study of 6-methoxyquinolineN-oxide dihydrate
  212. 4-Formyl-2-nitrophenyl 4-bromobenzoate
  213. X-ray Crystal Structures of Intermediates of the Stereoselective (±)-Grandisol Synthesis Based on the Remote Alkylation Protocol
  214. 2,2′-(Carbonothioyldisulfanediyl)bis(2-methylpropanoic acid)
  215. Synthesis, crystal structure and photoluminescence of a binuclear complex of europium(III) containing 3,5-dicarboxypyrazolate and succinate
  216. 2,4,6-Trinitrophenyl 4-chlorobenzoate
  217. 5-Chloroquinolin-8-yl furan-2-carboxylate
  218. Study of a series of cobalt(II) sulfonamide complexes: Synthesis, spectroscopic characterization, and microbiological evaluation against M. tuberculosis. Crystal structure of [Co(sulfamethoxazole)2(H2O)2]·H2O
  219. New ruthenium(II)/phosphines/diimines complexes: Promising antitumor (human breast cancer) and Mycobacterium tuberculosis fighting agents
  220. A new copper(II) complex with 2-thenoyltrifluoroacetone and 2,2-bipyridine: Crystal structure, spectral properties and cytotoxic activity
  221. Electrochemical and Monte Carlo studies of self-assembled trans-[Fe(cyclam)(NCS)2]+ complex ion on gold surface as electrochemical sensor for nitric oxide
  222. Hydrokenomicrolite, ( ,H2O)2Ta 2(O,OH)6(H2O), a new microlite-group mineral from Volta Grande pegmatite, Nazareno, Minas Gerais, Brazil
  223. cis-Bis(1,10-phenanthroline-κ2N,N′)bis(pyridin-4-amine-κN1)ruthenium(II) bis(hexafluoridophosphate)
  224. cis-Bis(2,2′-bipyridine-κ2N,N′)bis(pyridin-4-amine-κN1)ruthenium(II) bis(hexafluoridophosphate) acetonitrile monosolvate
  225. Understanding the Solid Forms of 5E-phenylethenylbenzofuroxan with Differentin vivoanti-T. cruziActivity
  226. 16α-Hydroxyfriedelin and 3-Oxo-16-methylfriedel-16-ene as Building Blocks: Crystal Structure and Hirshfeld Surfaces Decoding Intermolecular Contacts
  227. Novel sesquiterpene lactones from Eremanthus seidelii
  228. Crystal Structure of Limonoid 6-O-Acetylswietephragmin E and Theoretical Study of Nuclear Magnetic Resonance Spectra of Phragmalin Limonoids
  229. 3,5-Bis(benzyloxy)benzoic acid
  230. 2,4,6-Trinitrophenyl 4-methylbenzoate
  231. Base-Paired and Base-Stacked Structures of the Anti-HIV Drug Lamivudine: A Nucleoside DNA-Mimicry with Unprecedented Topology
  232. Synthesis, crystal structure and magnetic properties of the helical oxalate-bridged copper(II) chain {[(CH3)4N]2[Cu(C2O4)2] · H2O}n
  233. Ethyl 2-(3-phenylthioureido)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate
  234. Synthesis and characterization of [Ru(η6-C10H14)(dppf)X][PF6] (X=Cl, Br, I, SnF3) compounds: The X-ray structure of [Ru(η6-C10H14)(dppf)Cl][SnCl3]·0.45CH2Cl2
  235. 2,4,6-Trinitrophenyl 3-methylbenzoate
  236. 6-Bromopyridine-2-carbaldehyde phenylhydrazone
  237. Lamivudine Salts with Improved Solubilities
  238. 9-(4-Bromobutyl)-9H-carbazole
  239. Synthesis and characterization of the atropisomeric relationships of a substituted N-phenyl-bipyrazole derivative with anti-inflammatory properties
  240. Inhibition of cysteine proteases by a natural biflavone: behavioral evaluation of fukugetin as papain and cruzain inhibitor
  241. Cyclopropane- and spirolimonoids and related compounds from Hortia oreadica
  242. Host–guest interactions between xanthones and water: the role of O–H···O, C–H···O, and π···π contacts in the channel- and cage-type frameworks
  243. Pseudopolymorphism in hydroxybenzophenones: the dihydrate of 2,2′,4,4′-tetrahydroxybenzophenone
  244. Influence of hydrogen bonds on the molecular structure and conformations of two (C30H48O2) pentacyclic triterpene isomers
  245. Salts of the anti-HIV drug lamivudine with phthalic and salicylic acids
  246. Toward supramolecular architectures of the anti-HIV drug lamivudine: understanding the effect of the inclusion of water in a hydrochloride form
  247. Form III-like conformation and Form I-like packing in a chloroform channel solvate of the diuretic drug chlortalidone
  248. X-ray diffraction and theoretical investigation of the Gedunin crystal structure
  249. Preparation, characterization and structure of ruthenium phosphine complexes containing non-innocent ligands
  250. Hydrothermal syntheses of ETS-10 like vanadosilicates using chiral organic molecules. Part I
  251. 4-Methylphenyl 4-bromobenzoate
  252. Ruthenium(II) phosphine/diimine/picolinate complexes: Inorganic compounds as agents against tuberculosis
  253. Syntheses, crystal structure and theoretical investigation of novel heteroleptic complexes of nickel(II) with N-R-sulfonyldithiocarbimate and phosphine ligands
  254. Rankamaite from the Urubu pegmatite, Itinga, Minas Gerais, Brazil: Crystal chemistry and Rietveld refinement
  255. Weak C—H...Cl—Pd interactions toward conformational polymorphism intrans-dichloridobis(triphenylphosphane)palladium(II)
  256. A monoclinic polymorph of the ticlopidine hydrochloride
  257. Crystal structure of the drug diethylcarbamazine and a new maleate salt
  258. Supramolecular chemistry of anti-HIV nucleoside drugs: toward smart crystal phases and self-assembled DNA-mimicries
  259. Asymmetric heterobimetallic mixed-valence complex trans-[(SO3)Co(cyclam)(NCS)Ru(NH3)4(NCS)](BF4): Synthesis and characterization
  260. Experimental and theoretical investigation of molecular structure and conformation of the 4-isopropylthioxanthone
  261. fac-/mer-[RuCl3(NO)(P–N)] (P–N=[o-(N,N-dimethylamino)phenyl]diphenylphosphine): Synthesis, characterization and DFT calculations
  262. Conformational polymorphism of the antidiabetic drug chlorpropamide
  263. cis-Bis[1,1-dibenzyl-3-(furan-2-ylcarbonyl)thioureato-κ2O,S]copper(II)
  264. THE CRYSTAL STRUCTURE OF A MICROLITE-GROUP MINERAL WITH A FORMULA NEAR NaCaTa2O6F FROM THE MORRO REDONDO MINE, CORONEL MURTA, MINAS GERAIS, BRAZIL
  265. Study of the phenanthroline-Mn-imidazole bonding in Mn(I) triscarbonyl complex: A X-ray and DFT computational analysis
  266. cis-Bis{1,1-dibenzyl-3-[(furan-2-yl)carbonyl]thioureato-κ2O,S}nickel(II)
  267. Tetrachlorocarbonyliridates: Water-Soluble Carbon Monoxide Releasing Molecules Rate-Modulated by the Sixth Ligand
  268. Synthesis and Crystal Structures of Octahedral Sn(IV) Complexes Prepared from SnCl2·2H2O and 2-Hydroxyacetophenone (S-benzydithiocarbazate) Ligand (H2L)
  269. 4-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoic acid: X-ray and DFT-calculated structure
  270. Design of 1D and 2D molecule-based magnets with the ligand 4,5-dimethyl-1,2-phenylenebis(oxamato)
  271. Increasing the symmetry of drug crystals: a monoclinic conformational polymorph of the platelet antiaggregating agent ticlopidine hydrochloride
  272. The mer-[RuCl3(dppb)(H2O)] complex: A versatile tool for synthesis of RuII compounds
  273. 2-(Phenylcarbonothioylsulfanyl)acetic acid
  274. 3-Nitrophenol–4,4′-bipyridylN,N′-dioxide (2/1): a DFT study and CSD analysis of DPNO molecular complexes
  275. Triple Structural Transition below Room Temperature in the Antifilarial Drug Diethylcarbamazine Citrate
  276. Coordination of nitro-thiosemicarbazones to ruthenium(II) as a strategy for anti-trypanosomal activity improvement
  277. On the synthesis and structures of the complexes [RuCl(L)(dppb)(N–N)]PF6 (L=CO, py or 4-NH2py; dppb=1,4-bis(diphenylphosphino)butane; N–N=2,2′-bipyridine or 1,10-phenanthroline) and [(dppb)(CO)Cl2-Ru-pz-RuCl2(CO)(dppb)] (pz=pyrazine)
  278. Oxorhenium(V) Complexes with 2,3-Dihydroxynaphthalene
  279. 2-[(2-Carboxyphenyl)disulfanyl]benzoic acid–4,4′-bipyridylN,N′-dioxide (1/2)
  280. ChemInform Abstract: 6-Deoxyjacareubin.
  281. ChemInform Abstract: Serendipitous, One-Pot Formation of 2,3,7-Triphenylcyclopenta[c]pyran from 1,2-Diphenylethanedione (“Benzil”) and Cyclopentadiene.
  282. Synthesis, characterization and cytotoxic activities of the [RuCl2(NO)(dppp)(L)]PF6 complexes
  283. Solvothermal Preparation of Drug Crystals: Didanosine
  284. From Rational Design of Drug Crystals to Understanding of Nucleic Acid Structures: Lamivudine Duplex
  285. Structural and magnetic properties of the oxyborateCo5Ti
  286. On the relationships between molecular conformations and intermolecular contacts toward crystal self-assembly of mono-, di-, tri-, and tetra-oxygenated xanthone derivatives
  287. Novel ruthenium complexes as potential drugs for Chagas's disease: enzyme inhibition and in vitro/in vivo trypanocidal activity
  288. Dependence of the product on the P–P ligand in reactions of [RuCl3(NO)(P–P)] complexes (P–P=aromatic diphosphines) with 2-mercaptopyridine
  289. Experimental and theoretical study of the kinetics of dissociation in cis-[RuCl2(P-P)(N-N)] type complexes
  290. Efficient synthesis of benzothiazine and acrylamide compounds
  291. A novel and simple synthetic route for a piperazine derivative
  292. Palladium(II) complexes with thiosemicarbazones: syntheses, characterization and cytotoxicity against breast cancer cells and Anti-Mycobacterium tuberculosis activity
  293. Crystal Engineering of an Anti-HIV Drug Based on the Recognition of Assembling Molecular Frameworks
  294. Structural relationships in the solid state of the anti-chagas agent (E)-phenylethenylbenzofuroxan
  295. Driving forces in substitution reactions of octahedral complexes: The influence of the competitive effect
  296. Synthesis, structural characterization and ex vivo biological properties of a new complex [Cu(propranolol)2]·2H2O, a potential beta-blocker
  297. Imidazolium fumarate
  298. Heterobimetallic compounds [Ru(η5-Cp)(dppf)X] (X = Cl, Br, I and N3): synthesis, electrochemical analysis, and the crystal structure of [Ru(η5-Cp)(dppf)I] [dppf = 1,1′-bis(diphenylphosphino)ferrocene]
  299. Bis(tetraphenylphosphonium) tris[N-(methylsulfonyl)dithiocarbimato(2−)-κ2S,S′]stannate(IV)
  300. Synthesis, characterization, and single crystal X-ray structure of the 1-furoyl-3-cyclohexylthiourea cadmium chloride complex, Cd[C4H3OC(O)NHC(S)NHC6H11]4Cl2
  301. Intermolecular contacts influencing the conformational and geometric features of the pharmaceutically preferred mebendazole polymorph C
  302. Conformational Polymorphism in Racemic Crystals of the Diuretic Drug Chlortalidone
  303. 3-Nitrobenzoic acid–3-methyl-4-nitropyridine 1-oxide (1/1)
  304. On an Electrode Modified by a Supramolecular Ruthenium Mixed Valence (Ru II /Ru III ) Diphosphine-Porphyrin Assembly
  305. Molecular conformation of the racemic indan derivative (±)-1-trans-3-(3,4-dichlorophenyl)-2,3-dihydro-1H-indene-1-carboxamide
  306. 4-{2-[4-(Dimethylamino)phenyl]ethylidene}benzonitrile
  307. Partial magnetic ordering and crystal structure of the ludwigitesCo2
  308. 1-Furoyl-3-[3-(trifluoromethyl)phenyl]thiourea
  309. Diphenyllead(IV) thiosemicarbazonates and pyrazolonates: Synthesis and characterization
  310. Redetermination of 1-benzyl-3-furoyl-1-phenylthiourea
  311. Preparation of Achiral and Chiral (E)-Enaminopyran-2,4-diones and Their Phytotoxic Activity
  312. Spectroscopic Investigation on the Formation of a Dinuclear Me2SO–Ru2-Mercaptopyridine Bridged Complex: [Ru2Cl3(μ-pyS)(μ-dmso)(dmso)4] · 2H2O
  313. Lupeol
  314. Vanadium complexes with thiosemicarbazones: Synthesis, characterization, crystal structures and anti-Mycobacterium tuberculosis activity
  315. Novel 6-methanesulfonamide-3,4-methylenedioxyphenyl-N-acylhydrazones: Orally effective anti-inflammatory drug candidates
  316. Synthesis, structural characterization and conformational aspects of nostoclide analogues
  317. Organotin Complexes of Alizarin and Purpurin
  318. Different coordination modes for disulfoxides towards diorganotin(IV) dichlorides. X-ray crystal structures of 1,2-cis-bis-(phenylsulfinyl)ethene (rac-,cis-cbpse) and adducts [{Ph2SnCl2(meso-bpse)}n] and [{n-Bu2SnCl2(pdtd)}2]
  319. Study of the [Zn(H2O)4CuEDTA]·2H2O Complex, a Potential Trace-metal Supplier: Synthesis, Crystal Structure, Spectroscopic Behavior and Metal Release
  320. Analyzing Ru(III)–dmso and Ru(III)–dms motifs in compounds used in the synthesis of the antimetastatic agents
  321. N-(4-Chlorophenyl)maleimide
  322. Rhenium chelate complexes with maltolate or kojate
  323. Synthesis, characterization, X-ray structure and in vitro antimycobacterial and antitumoral activities of Ru(II) phosphine/diimine complexes containing the “SpymMe2” ligand, SpymMe2=4,6-dimethyl-2-mercaptopyrimidine
  324. Powder X-ray diffraction study of polymorphic drugs: fluconazole and mebendazole
  325. 1-(o-Tolyl)thiourea
  326. N-(2-Furylcarbonyl)piperidine-1-carbothioamide
  327. 1-(2-Furoyl)-3-(o-tolyl)thiourea
  328. Crystal Structure of Garciniaphenone and Evidences on the Relationship between Keto-Enol Tautomerism and Configuration
  329. Hydrogen bonding in 2-(2-oxothiazolidin-3-yl)-4,5-dihydrothiazolium hydrogen sulfate monohydrate
  330. 1-(3-Cyanophenyl)-3-(2-furoyl)thiourea
  331. Quantum-chemical, NMR and X-ray diffraction studies on (±)-1-[3,4-(methylenedioxy)phenyl]-2-methylaminopropane
  332. 1-Furfuryl-3-furoylthiourea
  333. Structure and magnetism of homometallic ludwigites:Co3O
  334. Synthesis and Characterization of a New Copper(II) Complex with Nadolol, an Aminoalcoholic Beta-blocker. Crystal Structure of Na[Cu(nadololate)(CO3)] · H2O
  335. N-(3-Chlorophenyl)maleimide
  336. 8-Hydroxy-5,6,7-trimethoxy-2-phenyl-4H-chromen-4-one
  337. Lead(II)-induced formation and coordination of 3,4-dihydro-3-thioxo-1,2,4-triazin-5(2H)-one
  338. Dimethylthallium(III) complexes with picolinic acid and its hydroxyl derivatives
  339. Ruthenium(II) complexes containing N(4)-tolyl-2-acetylpyridine thiosemicarbazones and phosphine ligands: NMR and electrochemical studies of cis–trans isomerization
  340. Crystal Structures and Thermal Behavior of Alkaline Earth Tricyanomethanides
  341. New Ni(II)-sulfonamide complexes: Synthesis, structural characterization and antibacterial properties. X-ray diffraction of [Ni(sulfisoxazole)2(H2O)4]·2H2O and [Ni(sulfapyridine)2]
  342. Menezesite, the first natural heteropolyniobate, from Cajati, Sao Paulo, Brazil: Description and crystal structure
  343. Synthesis and Characterization of a New Mebendazole Salt: Mebendazole Hydrochloride
  344. New insights on the Lewis acidity of diorganolead(IV) compounds: Diphenyllead(IV) complexes with N,O,S-chelating ligands
  345. Synthesis of novel O-acylated-D-ribono-1,5-lactones and structural assignment supported by conventional NOESY-NMR and x-ray analysis
  346. Sobre uma degenerescência acidental nos deslocamentos químicos de RMN de 31P{¹H} em complexos difosfínicos de rutênio
  347. Crystalline Structure of Mangiferin, aC-Glycosyl-Substituted 9H-Xanthen-9-one Isolated from the Stem Bark ofMangifera indica
  348. New Pd(II) and Pt(II) complexes with N,S-chelated pyrazolonate ligands: Molecular and supramolecular structure and preliminary study of their in vitro antitumoral activity
  349. Novel manganese (III) porphyrin containing peripheral “[RuCl(dppb)(X-bipy)]+” cations [dppb=1,4-bis(diphenylphosphino)butane and X=–CH3, –OMe, –Cl]. X-ray structure of the cis-[RuCl(dppb)(bipy)(4-Mepy)]PF6 complex
  350. Low-temperature study of a new nevirapine pseudopolymorph
  351. 2-Benzoylpyridine semicarbazone
  352. Synthesis, characterization and crystal structure of a novel thiocyanate–ruthenium(II) complex
  353. Heterobimetallic [Ru(II)/Fe(II)] complexes: On the formation of trans- and cis-[RuCl2(dppf)(diimines)]
  354. Synthesis, characterization, X-ray structure and preliminary in vitro antitumor activity of the nitrosyl complex fac-[RuCl3(NO)(dppf)], dppf=1,1′-bis(diphenylphosphine)ferrocene
  355. Crystal structure, electrochemical and photochemical studies of the trans-[Fe(cyclam)(NO)Cl]Cl2 complex (cyclam=1,4,8,11-tetraazacyclotetradecane)
  356. New lead(II) complexes with N,S-ligands, including a lead pyrazolonate with unusual packing flexibility
  357. Crystal structure and anticonvulsant activity of (±)-1,2:4,5-di-O-isopropylidene-3,6-di-O-(2-propylpentanoyl)-myo-inositol
  358. X-ray structure and EPR behavior of a new dimeric copper(II) complex with 4-amino-N-(5-methoxy-2-pyrimidinyl)benzenesulfonamide
  359. Methyllead(IV) Derivatives Stabilized by DAPTSC2–: Synthesis and Structures of New Diorganolead(IV) Complexes
  360. Novel Gold(I) 7-Azacoumarin Complex:  Synthesis, Structure, Optical Properties, and Cytotoxic Effects
  361. Synthesis and structural characterization of two nostoclide analogues
  362. Correlation between quadrupole splitting (Δ) and the θ angle (C–Sn–C) in five-coordinate diphenyltin(IV) complexes. X-ray crystal structures of [Ph2Sn(hacm)] and [Ph2Sn(hacmm)] containing O,N,S-tridentate N 4-heterocyclic thiosemicarbazones
  363. 2,2′,4-Trihydroxybenzophenone: Crystal Structure, and Anti-Inflammatory and Antioxidant Activities
  364. Physicochemical characterization of deflazacort: Thermal analysis, crystallographic and spectroscopic study
  365. The preparation of new oxoniobium(V) complexes from hydrated Niobium(V) Oxide: the crystal and molecular structure of Oxotris(2-pyridinolato-N-oxide)niobium(V)
  366. Pseudohalides of Main Group Metals: The Alcaline Earth Tricyanomethanides - The Crystal Structures of Calcium and Barium Tricyanomethanide.
  367. Natural polyprenylated benzophenones: keto-enol tautomerism and stereochemistry
  368. The first P–N containing RuCl3NO complex: fac-[RuCl3(NO)(P–N)] (P–N=[o-(N,N-dimethylamino)phenyl]diphenylphosphine)
  369. Novel zwitterionic oxorhenium(V) complexes: synthesis, characterization and crystal structure of [ReOX2(Hdhp)(PPh3)] (X = Cl, Br; H2dhp = 2,3-dihydroxypyridine)
  370. Matioliite, the Mg-analog of burangaite, from Gentil mine, Mendes Pimentel, Minas Gerais, Brazil, and other occurrences
  371. A gold(I) complex with a vitamin K3 derivative: Characterization and antitumoral activity
  372. 7-Amino-1-(3-bromophenyl)-3-cyanopyrazolo[4,3-d]pyrimidine
  373. A duplicated nitrotienyl derivative with antimycobacterial activity: synthesis, X-ray crystallography, biological and mutagenic activity tests
  374. Structural characterization of a series of new Cu-dipeptide complexes in solid state and in solution
  375. Magnetic properties of copper(II) complexes containing peptides. Crystal structure of [Cu(phe-leu)]
  376. Synthesis, 119Sn Mössbauer spectroscopic studies and X-ray crystal structure determination of new seven-coordinate diorganotin(IV) complexes with S,N,N,N,S-pentadentate Schiff bases derived from 2,6-diacetylpyridine of S-methyl- and S-benzyldithiocarba...
  377. On a ruthenium nitrosyl and monocoordinated biphosphine monoxide complex: Synthesis, characterization and X-ray structure of
  378. Preparation, crystal structure and spectroscopic characterization of nickel(II) complexes with dithiocarbimate derivated of sulfonamides
  379. Copper complexes with heterocyclic sulfonamides: Synthesis, spectroscopic characterization, microbiological and SOD-like activities: Crystal structure of [Cu(sulfisoxazole)2(H2O)4]·2H2O
  380. Structure and Vasorelaxant Activity of Floranol, a Flavonoid Isolated from the Roots ofDioclea grandiflora
  381. Influence of ligands on the isomerization in [RuCl3(NO)(P–P)] complexes, [P–P=R2P(CH2)nPR2 (n=1–3) and R2P(CH2)POR2, PR2–CHCH–PR2, R=Ph and (C6H11)2P-(CH2)2-P(C6H11)2]
  382. Mammeigin
  383. Polymorphism on Leflunomide: Stability and Crystal Structures
  384. The versatility of the 1,4-dithiane ligand towards the coordination chemistry of ruthenium-phosphine complexes
  385. The role of solvent in coordination polymers: The structures of catena-[Hg(μ2-O2PPh2)2] and catena-[Hg(μ2-O2PPh2)2(NC5H5)2]
  386. Experimental and theoretical structure characterization of two isoniazid derivatives: 2,4-Difluoro-N′-isonicotinoylbenzohydrazide and 2,4-dichloro-N′-isonicotinoylbenzohydrazide hydrochloride
  387. Ruthenium Phosphine/Diimine Complexes: Syntheses, Characterization, Reactivity with Carbon Monoxide, and Catalytic Hydrogenation of Ketones.
  388. Bis(diphenylphosphinato-κO)bis(diphenylphosphinic acid-κO)bis(pyridine-κN)mercury(II)
  389. Mono- and dinuclear copper(I) complexes with methyl-substituted pyrimidinethiones
  390. A pentacyclic triterpene from Maytenus imbricata: structure elucidation by X-ray crystallography
  391. Synthesis, characterisation and molecular structure of stannyl derivatives of molybdenum and iron
  392. Zinc(II), cadmium(II) and mercury(II) complexes of the vitamin B1 antagonist oxythiamine
  393. Synthesis, characterization and structure of ruthenium(II) phosphine complexes with N-heterocyclic thiolate ligands
  394. A Crystalline Phase Transition and Optical Properties in a CoIICuII Oxamato-Bridged Ferrimagnetic Chain
  395. Ruthenium Phosphine/Diimine Complexes:  Syntheses, Characterization, Reactivity with Carbon Monoxide, and Catalytic Hydrogenation of Ketones†
  396. The RuCl3(dppb)H2O complex: A new metal-assisted oxidative dehydrogenation of the o-phenylenediamine ligand
  397. Leaf-cutting ants toxicity of limonexic acid and degraded limonoids from Raulinoa echinata.: X-ray structure of epoxy-fraxinellone
  398. Limonoids from Spiranthera odoratissima St. Hil
  399. Synthesis and characterization of nitrosyl complexes containing 4,6-dimethyl-pyrimidine-2-thiolato (‘SpymMe2’) as ligand: [Ru(‘SpymMe2’,-N,-S) (‘SpymMe2’,-S)(NO)(P–P)](PF6) (P–P=1,2-bis(diphenylphosphino)ethane or 1,2-bis(diphenylphosphino)ethylene
  400. Magnetic and structural properties of two open-frameworks Nd(III) adipates
  401. Structural insights of a potential inhibition against leishmania major
  402. Factors determining polymorphism of leflunomide
  403. Magnetic and structural properties of rare earth hybrid frameworks
  404. Experimental electron density of [Cu(phen)2Cl](NO3)(H2O)
  405. An Alternative Method for the Preparation of Diphenylboron Chelates. The Crystal and Molecular Structures of (Pyridine-2-acetyloximato)diphenylboron and (1-Phenylazo-2-naphtholato)diphenylboron
  406. Molecular and Supramolecular Structures of 1-Phenyl-4-phenylacetyl-2-thiosemicarbazide (H2L) and its Complexes with Diphenyllead(IV) Chloride and Acetate
  407. Electron density distribution in the pyroborateMn2B...
  408. 5-Nitro-2-furaldehydeN-(hydroxymethyl)semicarbazone
  409. Ruthenium complexes containing the hemilabile ligand PPh2(CH2)P(O)PPh2 (dppmO): reactivity towards CO and X-ray molecular structures of tcc-RuCl2(η2-dppmO)2 and mer-RuCl3(η1,η2-dppmO)2
  410. New pyrone and quinoline alkaloid from Almeidea rubra and their trypanocidal activity
  411. The synthesis and characterisation of Sn(IV) complexes of 2,6-pyridine dicarboxylate — the molecular structure of divinyltin(IV) derivative
  412. Layered poly[μ2-aqua-μ3-dimethylformamide-di-μ3-phenylphosphonato-dipotassium]
  413. Synthesis, characterization, and structure of a new N-nitrosamine of cyclam (1,4,8,11-tetraazacyclotetradecane)
  414. 31P{1H}-n.m.r. as a tool for identification of ruthenium isomers containing PPh3 or 1,4-bis(diphenylphosphino)butane ligands. X-ray structures of the cis-{RuCl2(PPh3)2 [4,4′-(-X)2-2,2′-bipy]} complexes [X=-H, -Me, -SMe and (-Cl, -Me)]
  415. Candesartan cilexetil, an antihypertensive agent containing an extended double ester chain
  416. mer-[RuCl3(P–P)H2O] (P–P=dppb or diop) as a starting material for the synthesis of binuclear complexes. Crystallographic structures of [(dppb)ClRu–μ(Cl)3–RuCl(dppb)] and [(η6-C6H6)Ru–μ(Cl)3–RuCl(dppb)].Imine hydrogenation using mono- and binuclear ruth...
  417. Polymeric chains, hydrogen bonds and magnetism in Nd(III) adipates
  418. Aurapten, a coumarin with growth inhibition against Leishmania major promastigotes
  419. Neo-clerodane diterpenoid, a new metalloprotease snake venom inhibitor from Baccharis trimera (Asteraceae): anti-proteolytic and anti-hemorrhagic properties
  420. mer-[RuCl3(P–P)H2O] (P–P=dppb or diop) as a starting material for the synthesis of binuclear complexes. Crystallographic structures of [(dppb)ClRu–μ(Cl)3–RuCl(dppb)] and [(η6-C6H6)Ru–μ(Cl)3–RuCl(dppb)].
  421. Syntheses, characterization and X-ray structure of potassium hydrotris(2-mercaptothiazolyl)borate, KMt, and potassium hydrotris(methimazole)borate, KTm
  422. N2,S-versus N3,S-coordination in thiosemicarbazonate complexes: only a steric influence?
  423. Crystal structure and spectral characterization of dimethylthallium (III) complexes with 2-mercaptonicotinic acid and esters
  424. The effect of the cation substitution on the structural and vibrational properties of Cs2NaGaxSc1−xF6 solid solution
  425. Crystal structure and vibrational spectrum of the NaCaMg2F7 pyrochlore
  426. The synthesis and structural characterisation of [Ru(η-Cp)(dppf)SnBr3]
  427. Synthesis, characterisation and thermal decomposition of tin(IV) dithiocarbamate derivatives – single source precursors for tin sulfide powders
  428. Synthesis, Structural, Spectroscopic and Electrochemical Characterization of New Ruthenium(II) Tetramer Complexes Containing 1,4-Bis(diphenylphosphine)butane and Alterdentate Ligands
  429. Reaction of R(Ph)SnCl2(R=Me, Et) with 2,6-diacetylpyridine bis(thiosemicarbazone) (H2DAPTSC): the crystal structures of [Me(Ph)Sn(HDAPTSC)]Cl·1.25 MeOH and [Et(Ph)Sn(H2DAPTSC)]Cl2·MeOH·H2O
  430. Crystallographic report: Supramolecular structure of 2-aminonicotinatodimethylthallium(III),[TlMe2(2anic)]n
  431. Preparation, crystal structure and spectroscopic characterization of novel N-R-sulfonyldithiocarbimate platinum(II) complexes
  432. The Reaction of Dimethyltin(IV) Dichloride with Thiamine Diphosphate (H2TDP):  Synthesis and Structure of [SnMe2(HTDP)(H2O)]Cl·H2O, and Possibility of a Hitherto Unsuspected Role of the Metal Cofactor in the Mechanism of Vitamin-B1-Dependent Enzymes
  433. Structural, spectroscopic and redox studies of a new ruthenium(III) complex with an imidazole-rich tripodal ligand
  434. The Zn2+salt of pamidronate: a role for water in the metal–cation binding properties of bisphosphonates
  435. Crystallographic report: Ethyltriphenyltin(IV), Et(Ph)3Sn
  436. Potassium tetrakis(2-mercaptothiazolyl)borate; an open-framework material: synthesis and X-ray structure analysis
  437. A new monoclinic polymorph of methylp-aminobenzoate
  438. New thallium(III) chloride complexes with pyridine carboxylic acids: from molecular compounds to supramolecular associations
  439. Synthesis, crystal structures and spectroscopic properties of dichloroethylphenyltin(IV) and its phenanthroline adduct
  440. Dichloro(diphosphine)(2-pyridyl-ketone)ruthenium(II) complexes
  441. New Crystals in the Lithium Sulfate Family.
  442. 3-(5,7-Dimethoxy-2,2-dimethyl-2H-benzo[b]pyran-6-yl)propionic acid: a potential inhibitor against Leishmania
  443. Redetermination of skimmianine: a new inhibitor against the Leishmania APRT enzyme
  444. Redetermination and comparative structural study of isopimpinellin: a new inhibitor against the Leishmania APRT enzyme
  445. New crystals in the lithium sulfate family
  446. Design, Synthesis, and Evaluation of Analogues of 3,3,3-Trifluoro-2-Hydroxy-2-Phenyl-Propionamide as Orally Available General Anesthetics
  447. 3-(Benzoxazol-2-yl)-7-hydroxychromen-2-one methanol solvate
  448. Two members of the bisphosphonate class of drugs: a zwitterion and a molecular compound
  449. 2-Cyano-N-(2-hydroxyphenyl)acetamide
  450. Compositional and Structural Variety of Diphenyllead(IV) Complexes Obtained by Reaction of Diphenyllead Dichloride with Thiosemicarbazones
  451. Structure and magnetism ofMnMgB2
  452. 17α,21-Dihydroxy-16β-methylpregna-1,4-diene-3,11,20-trione (meprednisone)
  453. 4-(2-Isonicotinoylhydrazino)-4-oxobutanoic acid
  454. Synthesis and characterization of new ruthenium complexes with active ligands against Chagas' disease
  455. Redetermination of nickel bis(dithiocarbamate) at 100 K
  456. Synthesis, Spectroscopic and Structural Aspects of Mono‐ and Diorganothallium(III) Complexes of 2, 6‐Diacetylpyridine Bis(thiosemicarbazone) (H2DAPTSC) — A New Coordination Mode of the HDAPTSC— Anion
  457. 3-Oxoolean-12-en-20-yl α-methylcarboxylate
  458. A novel diterpene lactone
  459. fac-[RuCl3(NO)(dppb)] (I) and mer-[RuCl3(NO)(diop)] (II) complexes: syntheses, characterization and X-ray structures
  460. Novel Organophosphorus Cage Compound Produced by an Unexpected Oxidative Coupling of 1,2,4-Triphosphole: Crystal and Molecular Structures of Two Isomers of Formula P6C4Bu t4 CHSiMe3
  461. Syntheses, characterization and X-ray structures of the fac-[RuCl3(NO)(dppe)] and the trans-[RuCl(NO)(dppe)2]2+ species
  462. Charge density study of hexaaquazinc(II) dihydrogen-1,2,4,5-benzenetetracarboxylate
  463. Supramolecular organization in ruthenium complexes
  464. Supramolecular arrangement in dimethyl thallium complexes through Tl...S
  465. Crystal structure of cobalt-based chain molecular magnet CoCu(opba)(DMSO)3at room temperature and 100 K
  466. New Cages Derived from 1,2,4-Triphosphol
  467. Losartan potassium, a non-peptide agent for the treatment of arterial hypertension
  468. On the lability of dimethylsulfoxide (DMSO) coordinated to the {RuII–NO+} species: X-ray structures of mer-[RuCl3(DMSO)2(NO)] and mer-[RuCl3(CD3CN)(DMSO)(NO)]
  469. Single-crystal structure determination and infrared reflectivity study of the Li2CaHfF8 scheelite
  470. Crystal structure, electrochemical and spectroscopic properties of the trans-K{[FeCl(NO0)(cyclam)]·[FeCl(NO+)(cyclam)]2}(PF6)6 complex
  471. Metal-Induced Cyclization of Thiosemicarbazones Derived from β-Keto Amides and β-Keto Esters:  Open-Chain and Cyclized Ligands in Zinc(II) Complexes
  472. Supramolecular self-assembly in the crystal structures of methylmercury xanthates, MeHgS(S)COR, R=Et, iPr and CH2Ph
  473. Disodium pamidronate
  474. Synthesis and structure of cadmium and zinc complexes of dehydroacetic acid
  475. Epikatonic acid fromAustroplenckia populnea: structure elucidation by 2D NMR spectroscopy and X-ray crystallography
  476. Serendipitous, one-pot formation of 2,3,7-triphenylcyclopenta[c]pyran from 1,2-diphenylethanedione (“benzil”) and cyclopentadiene
  477. Structural Transition and Pair Formation inFe3
  478. 6-Deoxyjacareubin
  479. 1-(2-{4-[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiol-3-ylcarbonyl]phenoxy}ethyl)piperidinium chloride
  480. Role of the Hydrogen Bonds in Nitroanilines Aggregation:  Charge Density Study of 2-Methyl-5-nitroaniline
  481. A novel coordination mode for a pyridylphosphine ligand. X-ray structures of [RuCl2(NO)L] (I) and [RuCl2(NO)L]·DMSO (II) (L = [(2-py)2PC2H4POO(2-py)2]-)
  482. Structure and properties of iron–cyclam complex of 2-aminophenol
  483. THE CRYSTAL STRUCTURE OF DICHLORODIPHENYLBIPYRIDINE LEAD(IV), [PbPh2Cl2(bipy)]
  484. THE CRYSTAL STRUCTURE OF DIBROMOBIPYRIDINELEAD(II), [PbBr2(bpy)]
  485. THE CRYSTAL STRUCTURE OF DICHLORODIPHENYLPHENANTHROLINELEAD(IV), [PbPh2Cl2(phen)]
  486. Crystal structure and exchange pathways of the complex l-(trypthophyl-glycinato)copper(II)
  487. A novel coordination mode for a pyridylphosphine ligand. X-ray structures of [RuCl2(NO)L] (I) and [RuCl2(NO)L]·DMSO (II) (L = [(2-py)2PC2H4POO(2-py)2]-)
  488. Hydrogen Bonding in Nitroanilines:  Neutron Diffraction Study of m -Nitroaniline at 100 K
  489. Electrosynthesis of binuclear ruthenium complexes from [RuCl3(dppb)(L)] precursors [L = pyridine, 4-methylpyridine or dimethyl sulfoxide; dppb = 1,4-bis(diphenylphosphino)butane]
  490. Crystal structures of p-chlorobromobenzene and p-chloroiodobenzene
  491. Ba2Cu(HCOO)6, Thermal Behavior and Crystal Structure of the Room Temperature Phase
  492. Experimental evidence for the amino-group non-planarity in nitroanilines: neutron diffraction study of 2-methyl-5-nitroaniline at 100 K
  493. 3-Aryloxypropiononitriles Intermediates: Crystal and Molecular Structure of 2- and 4-(2-Bromoethoxy)diphenylmethanes
  494. 3-Aryloxypropiononitriles Intermediates: Crystal and Molecular Structure of 2- and 4-(2-Bromoethoxy)diphenylmethanes
  495. 2,4-Dinitro-N,N-methylphenylaniline
  496. 4-Benzyl-5-ethylthio-3H-1,2-dithiole-3-thione
  497. 2,4-Dinitrophenyl Phenyl Sulfone
  498. 4-Methyl-2-nitroaniline
  499. Structural studies of intermediates in a novel synthesis of aryloxypropiononitriles
  500. Conformational studies of substituted nitroanilines: geometry of 2-methyl-5-nitroaniline
  501. X-ray structural and spectroscopic investigation of 1-piperidine-2,4-dinitrobenzene